Related Experiment Video
Updated: Jul 4, 2026
06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Advanced primary peritoneal carcinoma: clinicopathological and prognostic factor analyses
Chao Zhang1, Xiao-ping Li, Heng Cui
1Gynecological Oncology Center, Peking University People's Hospital, Beijing 100044, China.
Journal of Zhejiang University. Science. B
|June 11, 2008
Summary
Prognosis for advanced primary peritoneal carcinoma (PPC) depends on pathologic subtype, chemotherapy regimen, and p53 overexpression. Comprehensive management including surgery and chemotherapy is crucial for better outcomes in PPC patients.
Area of Science:
- Gynecologic Oncology
- Oncologic Pathology
- Clinical Cancer Research
Background:
- Advanced primary peritoneal carcinoma (PPC) is a rare malignancy with variable prognoses.
- Identifying prognostic factors is essential for optimizing treatment strategies.
Purpose of the Study:
- To investigate clinicopathologic and molecular factors influencing the prognosis of advanced primary peritoneal carcinoma (PPC).
Main Methods:
- Retrospective analysis of 24 PPC cases.
- Immunohistochemical assessment of p53, Top2alpha, Ki-67, and Her-2/neu expression.
- Correlation of clinicopathologic and molecular markers with patient survival.
Main Results:
- Primary peritoneal serous papillary carcinoma (PPSPC) showed significantly longer survival than malignant mixed Mullerian tumor (MMMT).
- TP chemotherapy regimen resulted in better survival compared to the PAC regimen.
- Positive p53 immunostaining was associated with shorter progression-free survival (PFS).
Conclusions:
- Pathologic subtype, chemotherapy regimen, and p53 overexpression are significant prognostic factors for PPC.
- A comprehensive management plan including cytoreductive surgery and appropriate chemotherapy is recommended.
- Optimal debulking surgery alone may not guarantee improved survival.
Related Concept Videos
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...